Jewel focuses her practice on transactions, corporate and securities law, and general corporate matters. She counsels companies in a variety of industries. Jewel was a Summer Associate at Mintz in 2021 and 2022.
While earning her JD, Jewel served as a legal intern for an agricultural cooperative and food and beverage company, where she performed legal research and assisted compliance, marketing, and other teams with legal questions. She also interned with Greater Boston Legal Services’ CORI & Re-entry Program, where she assisted clients with sealing and expunging their criminal records, and with the NYC Commission on Human Rights.
In law school, she served as a teaching assistant for a Legal Research and Writing course and a student clinician in Northeastern School of Law’s Civil Rights and Restorative Justice Project, a teaching, research, and policy analysis program focused on anti-civil rights violence and injustices carried out during the period of 1930 to 1970.
viewpoints
PBMs Continue to Draw Federal Scrutiny: PBM Transparency Act of 2022
June 30, 2022 | Blog | By Bridgette Keller, Hassan Shaikh, Sergey Smirnov, Jewel Duberry-Douglas
As we noted in our last PBM Regulatory Roundup, there has been a wave of state regulation focused on PBM practices in the wake of Rutledge and Webhi. However, PBMs are also facing federal reform efforts. The Pharmacy Benefit Manager (PBM) Transparency Act of 2022 (the Act) was recently proposed in the U.S. Senate and intends to incentivize “fair and transparent” PBM practices, prohibit spread pricing and claw backs of payments to pharmacies, and empower the Federal Trade Commission (FTC) and state attorneys general in enforcement actions to stop “unfair and deceptive” PBM business practices.
At the same time, government watchdogs are also taking action: on June 7, 2022, the FTC announced that it would launch an inquiry into vertically integrated PBMs, and the Office of the Inspector General (OIG) for the Department of Health and Human Services expects to release a report in 2022 following completion of its analysis of Medicaid Managed Care Organization (MCO) PBM pricing.
